2024-03-25 17:33 | CC:PSYB | Psybio Therapeutics Corp | 0.01 | Symbol Change295 | Psybio Therapeutics downgraded to NEX |
2023-12-06 19:37 | CC:PSYB | Psybio Therapeutics Corp | 0.01 | Cease Trade/Suspend Company180 | Psybio Therapeutics suspended by BCSC |
2023-12-06 08:33 | CC:PSYB | Psybio Therapeutics Corp | 0.01 | Halt Trading170 | Psybio Therapeutics halted at the open |
2023-11-27 08:10 | CC:PSYB | Psybio Therapeutics Corp | 0.01 | Halt Trading170 | Psybio Therapeutics halted at the open |
2023-08-30 11:33 | CC:PSYB | Psybio Therapeutics Corp | 0.015 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-08-30 11:32 | CC:PSYB | Psybio Therapeutics Corp | 0.015 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-07-21 10:26 | CC:PSYB | Psybio Therapeutics Corp | 0.025 | News Release200 | Psybio gets green light from gov't to make tryptamines |
2023-05-30 16:41 | CC:PSYB | Psybio Therapeutics Corp | 0.025 | SEDAR MD & A815 | SEDAR MD & A |
2023-05-30 16:33 | CC:PSYB | Psybio Therapeutics Corp | 0.025 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-04-28 17:13 | CC:PSYB | Psybio Therapeutics Corp | 0.035 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2023-04-28 17:04 | CC:PSYB | Psybio Therapeutics Corp | 0.035 | SEDAR MD & A815 | SEDAR MD & A |
2023-04-20 18:39 | CC:PSYB | Psybio Therapeutics Corp | 0.04 | News Release200 | Psybio closes third tranche of private placement |